Latest News - Boston Scientific
Top Corporates Hub
Boston Scientific
IDEXX Gains 56.2% in a Year: What's Driving the Rally?
25.08.2025 12:47
IDXX shares surge 56.2% in a year, fueled by strong diagnostics growth, cloud software gains and an upbeat 2025 outlook.
HOLX vs. BSX: Which Healthcare Stock Has More Room to Grow?
25.08.2025 12:31
Two MedTech giants, one clear winner. Boston Scientific's momentum outpaces Hologic's cautious rise.
NMTC Stock Gains as FDA Clears OneRF System for Facial Pain Treatment
19.08.2025 14:13
NeuroOne stock rallies after FDA clears its OneRF system, a minimally invasive solution targeting severe facial pain, scheduled to launch in late 2025.
MDT Stock Falls Despite Q1 Earnings & Revenue Beat, FY26 EPS View Up
19.08.2025 13:48
Medtronic tops on Q1 earnings and revenues, raises full-year EPS outlook, but shares dip on board changes.
Cooper Companies' Innovation Fuels Growth Amid Macro Headwinds
19.08.2025 12:50
COO leans on innovation and diversification to fuel growth, but fertility softness, tariffs and inventory headwinds weigh on near-term outlook.
Labcorp Debuts First FDA-Cleared Blood Test for Alzheimer's, Stock Up
19.08.2025 12:05
LH launches the first FDA-cleared blood test for Alzheimer's, boosting access to early diagnosis and nudging its stock higher.
Jefferies Reiterates a Buy Rating on Boston Scientific Corporation (BSX), Sets a $130 PT
16.08.2025 01:43
Boston Scientific Corporation (NYSE:BSX) is one of the best stocks to invest in for beginners. In a report released on August 11, Matthew Taylor from Jefferies reiterated a Buy rating on Boston Scientific Corporation (NYSE:BSX) with a price target of $130.00. The rating update followed the company’s release of fiscal Q2 2025 earnings on July […]
Accuray Stock Down as Q4 Earnings Miss Estimates, Revenues Down Y/Y
14.08.2025 15:17
ARAY stock down after Q4 earnings miss estimates, with product sales hit by tariffs and regional demand softness.
Reasons to Hold HealthEquity Stock in Your Portfolio for Now
14.08.2025 15:05
HQY's HSA growth, AI-driven efficiencies, and strong Q1 results fuel optimism despite data security concerns.
Boston Scientific Watchman device procedure risk
14.08.2025 10:32
The device's procedure-related incidents could have a negative impact on the company’s sales.
Possible Bearish Signals With Boston Scientific Insiders Disposing Stock
13.08.2025 11:00
Many Boston Scientific Corporation ( NYSE:BSX ) insiders ditched their stock over the past year, which may be of...
US Durable Medical Equipment Market Forecast and Competitive Landscape Report 2025-2033 | Invacare, NOVA, Inogen, Thermo Fisher Scientific, Abbott, Medtronic, Baxter, B. Braun, Boston Scientific, BD
12.08.2025 08:42
The United States Durable Medical Equipment Market is projected to grow at a CAGR of 5.03% from 2025 to 2033, reaching $97.10 billion by 2033, driven by rising chronic diseases, an aging population, and increased home healthcare demand. Key segments include personal mobility devices and monitoring and therapeutic equipment, with top players like Invacare, Abbott, and Medtronic leading innovations. California and New York are vibrant markets due to their demographics and healthcare infrastructure
TEM's Q2 Earnings & Revenues Beat Estimates, Stock Up in Pre-Market
08.08.2025 12:47
Tempus AI posts a narrower Q2 loss and an 89.6% revenue surge, driven by genomics growth and new oncology-focused product launches.
Disposable Endoscopes Market Insights, Competitive Landscape, and Market Forecast 2024-2032 | Olympus, Boston Scientific, and Ambu Drive Market Innovation with Innovative Product Launches
08.08.2025 10:40
The disposable endoscopes market, segmented by product, application, end-user, and geography, is projected to expand significantly, reaching USD 5.74 billion by 2032 from USD 2.65 billion in 2024. Driven by rising healthcare-associated infections, chronic diseases, and technological advancements, North America is set to dominate this growth.Dublin, Aug. 08, 2025 (GLOBE NEWSWIRE) -- The "Disposable Endoscopes - Market Insights, Competitive Landscape, and Market Forecast - 2032" has been added to
Q2 Medical Devices & Supplies - Diversified Earnings: Boston Scientific (NYSE:BSX) Earns Top Marks
08.08.2025 03:31
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Boston Scientific (NYSE:BSX) and the rest of the medical devices & supplies - diversified stocks fared in Q2.
CMCT Announces 30,821-Square-Foot Lease to Boston Scientific Corporation at Penn Field, a 228,000-Square-Foot Creative Office Campus in Austin
05.08.2025 12:00
AUSTIN, Texas, August 05, 2025--CMCT signs 30,821 sf lease with Boston Scientific at 228,000 sf Penn Field Creative Office Campus in Austin bringing property to 93% leased
Janus Henderson Mid Cap Growth Managed Account Q2 2025 Commentary
05.08.2025 10:19
Janus Henderson Mid Cap Growth Managed Account returned 7.71% (gross) and the Russell Midcap® Growth Index returned 18.20%. Read more here.
Is It Worth Investing in Boston Scientific (BSX) Based on Wall Street's Bullish Views?
01.08.2025 13:30
The average brokerage recommendation (ABR) for Boston Scientific (BSX) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Boston Scientific Stock Outlook: Is Wall Street Bullish or Bearish?
01.08.2025 13:29
Boston Scientific has outperformed the broader market over the past year, and analysts are highly optimistic about the stock’s prospects.
Resmed Q4 Earnings & Revenues Beat Estimates, Stock Up, Margins Climb
01.08.2025 11:51
RMD tops Q4 earnings and revenue estimates with double-digit growth, rising margins and strong global device demand.